Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Monsanto wins GMO royalties case in Paraguay

Two judges have denied emergency injunction bids from soybean growers in Paraguay against Monsanto’s charging for royalties on its genetically modified glyphosate-tolerant Roundup Ready soybeans, national media report. The judges dismissed the action on the grounds that it was inadmissible due to the complex nature of the dispute. Newspaper ABC cites grower group APS saying that the patent Monsanto defends is an unduly “renewed” patent, and business group Central Unicoop that patents on living organisms are impermissible in Paraguay and the key issue is the payment deal Monsanto made with Paraguayan soybean grower groups lasting until 2014. The first case was brought last month ( Agrow No 658, p 15). That followed a similar case in Brazil, where growers had won an injunction, only for Monsanto later to win the right to charge with funds being paid into an escrow account ( Agrow No 654, p 13). The company’s second-generation soybean technology, Intacta RR2 Pro (MON87701xMON89788), has been approved in Paraguay this month (see this issue).



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts